BodyCoding
Research

Diabetes-Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

The researchers reviewed the clinical and imaging features of diabetes-associated cognitive impairment and the mechanisms linking diabetes to neurodegeneration. The article discusses emerging therapeutic strategies, including GLP-1 receptor agonists and SGLT2 inhibitors, and their potential neuroprotective effects.

What to check after reading

This is a review of diabetes-associated cognitive impairment, exploring the potential role of GLP-1 receptor agonists in cognitive protection.

Source

PubMed ↗

Calendar dates show when a case was added or scheduled. For event dates, check the original source.